ClinicalTrials.Veeva

Menu

Early Visual Functions in Patients at Risk of Developing Cerebral Visual Impairment. A Pilot Study

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Visual Impairment

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of the study is to assess visual function from neonatal age to 36 months of age in infants at risk of visual impairment due to brain lesion or ocular pathology

Enrollment

700 estimated patients

Sex

All

Ages

2 days to 36 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 34 weeks of post-menstrual age and 36 months of life in children born before 37 weeks gestational age
  • Genetic syndroms
  • Hypoxic Hischemic Encephalopathy
  • Brain malformation
  • Metabolic diseases
  • Ocular pathologies

Exclusion criteria

  • Patients at low risk of developing neurological outcomes
  • Refusal of informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Daniela Ricci, Medical Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems